CLINICAL_TRIALS
trial_result
· 2013-01-01
Clinical Trial Update: Study of Alwextin® Cream in Treating Epidermolysis Bullosa [Phase 2]
Summary
Northwestern University completed a Phase 2 trial of Alwextin Cream for Epidermolysis Bullosa, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Epidermolysis Bullosa | Phase 2 | Status: COMPLETED | Results posted: 2013-01-01